If you needed any more reasons to cut consumption of processed foods, be sure to read this. Ultra-processed foods have been linked with a heightened risk for heart disease, stroke, and premature death by major studies. These foods include not just junk food like chips, cookies, and soda, but savory snacks, reconstituted meat products, and […]
The agency is doubling down on a bad guidance that endangers access to important medicines. Action Alert! Recently, the FDA announced the withdrawal of Compliance Policy Guide 400.400, a document that had been in place since 1988 and which established the agency’s enforcement policies regarding homeopathic medicines. In its place, the FDA has issued a […]
The USDA is considering a rule that would help close loopholes, but it doesn’t go far enough. Action Alert! The USDA’s National Organic Program (NOP) has reopened the comment period on the 2015 Origin of Livestock proposed rule that attempts to prevent large, industrial dairy and cattle operations from gaming the system. While the rule […]
The following article is by Dr. Jonathan V. Wright. The original article appears in the November 2019 issue of the Green Medicine Newsletter. Action Alert! The September 24th issue of the Journal of the American Medical Association (“JAMA”) reprinted[1] an article originally published in The Medical Letter on Drugs and Therapeutics which told us about the […]
TDF drugs are antiretrovirals used to treat HIV. Gilead Sciences markets TDF in combination with other drugs under the brand name Truvada, as well as other names such as Atripla, Complera, Stribild, Symfi-Lo, Cimduo and Viread. Studies have found TDF drugs to be damaging to the kidneys and bones—dangers that were not properly disclosed to […]
Millions of Americans have taken PPIs like Prilosec, Nexium and Prevacid to treat heartburn. These drugs have been promoted as a safe and more effective alternative to other antacid treatments and have been widely prescribed. These drugs, however, can allegedly cause extensive kidney damage. Numerous studies have shown the potential for injury from PPI use, […]
Incretin mimetics are a class of drugs used to Type 2 diabetes. Recent studies have shown that incretin mimetics are linked with pancreatic cancer. In 2013, the FDA released unpublished academic research that demonstrated pre-cancerous cellular changes known as pancreatic duct metaplasia in Type 2 diabetic patients treated with incretin mimetics. Incretin mimetics act like […]
Taxotere is a plant alkaloid chemotherapy drug derived from the yew tree. Taxotere is used intravenously in patients with locally advanced or metastatic breast cancer (after failure of prior chemotherapy) and in conjunction with doxorubicin and cyclophosphamide in patients with operable node-positive breast cancer. Unfortunately, it appears as though Taxotere is no more effective than […]
Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminated with N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA). These impurities may have the potential to cause […]
Xeljanz is a drug used to treat rheumatoid arthritis and ulcerative colitis. Unfortunately, after Xeljanz was approved the FDA issued a safety warning on the drug, regarding an increased risk of blood clots and of death with the 10 mg twice daily dose of Xeljanz. If you have taken the 10mg twice daily dose of Xeljanz […]